BRANDI H DYER
Allopathic & Osteopathic Physicians|Allergy & Immunology RICHMOND, KY NPI 1275705014
Browse related groups: Allopathic & Osteopathic Physicians|Allergy & Immunology KY Regeneron Healthcare Solutions, Inc. All categories
General Payments — all program years on this page
$2,841.60
- Category: General Payments
- Program years: PY2018–2024
- Record count: 181
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $133.88 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $120.12 | 7 |
| Education | $13.76 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $41.62 | 2 |
| Acerta Pharma LLC | $34.65 | 2 |
| GENZYME CORPORATION | $15.12 | 1 |
| Amgen Inc. | $14.82 | 1 |
| GlaxoSmithKline, LLC. | $13.91 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.76 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1104369655 | AstraZeneca Pharmaceuticals LP | $17.88 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105637032 | AstraZeneca Pharmaceuticals LP | $16.77 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111567221 | Amgen Inc. | $14.82 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114041337 | Regeneron Healthcare Solutions, Inc. | $17.01 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114041339 | Regeneron Healthcare Solutions, Inc. | $24.61 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116631486 | GlaxoSmithKline, LLC. | $13.91 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1137536799 | Takeda Pharmaceuticals U.S.A., Inc. | $13.76 | 06/26/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1139791559 | GENZYME CORPORATION | $15.12 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.